Drug Type Small molecule drug |
Synonyms NQP 1598, VT 1598 |
Target |
Action inhibitors |
Mechanism fungal CYP51A1 inhibitors(Fungal CYP51A1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC31H20F4N6O2 |
InChIKeyUDGASIIGNCBLSI-PMERELPUSA-N |
CAS Registry2089320-99-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coccidioidomycosis | Phase 1 | United States | 29 Sep 2020 | |
Mycoses | Preclinical | United States | 15 Sep 2017 |
Phase 1 | 48 | (40 mg Fasted) | ivebagmifq = dswofgjlnb ikaucucrfj (njyktuuian, liojooztml - qdolhbqwvm) View more | - | 11 Jan 2023 | ||
(80 mg Fasted) | ivebagmifq = szwddcpgpj ikaucucrfj (njyktuuian, bjtwflcibj - ciipgczvua) View more |